Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
Titel:
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer
Auteur:
Nakhlis, Faina Niman, Samuel M. Ueno, Naoto T. Troll, Elizabeth Ryan, Sean Yeh, Eren Warren, Laura Bellon, Jennifer Harrison, Beth Iwase, Toshiaki Carisa Le-Petross, H. T. Saleem, Sadia Teshome, Mediget Whitman, Gary J. Woodward, Wendy A. Overmoyer, Beth Tolaney, Sara M. Regan, Meredith Lynce, Filipa Layman, Rachel M.